Zhejiang Xianju Pharmaceutical Co Ltd (002332) — Capital Reinvestment Ratio
Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Capital Reinvestment Ratio of 0.23x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥130.05 Million) in capital expenditures (CN¥30.01 Million). See Zhejiang Xianju Pharmaceutical Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Xianju Pharmaceutical Co Ltd Capital Reinvestment Ratio (2006–2025)
This chart tracks Zhejiang Xianju Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 20 annual periods. Check 002332 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Xianju Pharmaceutical Co Ltd from 2006 to 2025. For live market cap and broader valuation context, see how much is Zhejiang Xianju Pharmaceutical Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.84x | CN¥247.48 Million | CN¥209.07 Million | ▲ +62.2% |
| 2024 | 0.52x | CN¥398.66 Million | CN¥207.59 Million | ▲ +32.2% |
| 2023 | 0.39x | CN¥595.48 Million | CN¥234.63 Million | ▼ -15.0% |
| 2022 | 0.46x | CN¥609.28 Million | CN¥282.54 Million | ▲ +17.5% |
| 2021 | 0.39x | CN¥676.15 Million | CN¥266.84 Million | ▲ +163.6% |
| 2020 | 0.15x | CN¥789.23 Million | CN¥118.17 Million | ▼ -70.3% |
| 2019 | 0.50x | CN¥519.81 Million | CN¥262.34 Million | ▼ -42.4% |
| 2018 | 0.88x | CN¥193.27 Million | CN¥169.26 Million | ▲ +19.0% |
| 2017 | 0.74x | CN¥167.47 Million | CN¥123.28 Million | ▲ +18.2% |
| 2016 | 0.62x | CN¥155.91 Million | CN¥97.10 Million | ▲ +8.1% |
| 2015 | 0.58x | CN¥199.61 Million | CN¥115.05 Million | ▼ -24.6% |
| 2014 | 0.76x | CN¥141.64 Million | CN¥108.26 Million | ▼ -74.4% |
| 2013 | 2.98x | CN¥63.46 Million | CN¥189.26 Million | ▼ -66.5% |
| 2012 | 8.91x | CN¥33.43 Million | CN¥298.01 Million | ▲ +380.1% |
| 2011 | 1.86x | CN¥147.63 Million | CN¥274.14 Million | ▲ +360.8% |
| 2010 | 0.40x | CN¥155.29 Million | CN¥62.58 Million | ▼ -1.8% |
| 2009 | 0.41x | CN¥104.68 Million | CN¥42.94 Million | ▼ -75.1% |
| 2008 | 1.64x | CN¥36.03 Million | CN¥59.25 Million | ▲ +135.0% |
| 2007 | 0.70x | CN¥96.53 Million | CN¥67.55 Million | ▲ +1.7% |
| 2006 | 0.69x | CN¥53.05 Million | CN¥36.51 Million | — |